Search





Search





Markets
/
Stocks
/
clgn
/

Collplant Biotechnologies Ltd

CLGN

Add to Watchlist

0.299USD

-0.001-0.30%

Close 07-31 16:00（ET）Quotes delayed by 15 min

3.82MMarket Cap

LossP/E TTM

Collplant Biotechnologies Ltd

0.299

-0.001-0.30%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

-0.30%

5 Days

-5.02%

1 Month

-14.30%

6 Months

-84.18%

Year to Date

-78.64%

1 Year

-87.64%

Key Figures

--Open

0.310High

51.48KVolume

LossP/E TTM

1.54P/E Dynamic

--Dividend TTM

0.40%Turnover Ratio

0.300Prev. Close

0.270Low

10.54KTurnover

LossP/E Static

0.41P/B

0.00%Div Yield TTM

-77.90%ROA

4.98052wk High

2.72Volume Ratio

-16.61MNet Profit

12.78MShares

-0.9415EPS TTM

0.92Beta

-117.56%ROE

0.49552wk Low

13.34%Amplitude

-332.88%Gross Margin

3.82MMarket Cap

-1.67Reward/Risk

7.08%Risk Rate

TradingKey Stock Score of Collplant Biotechnologies Ltd

Currency: USD Updated: 2026-07-31

Key Insights

Collplant Biotechnologies Ltd's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 204 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 11.00.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Collplant Biotechnologies Ltd's Score

Industry at a Glance

Industry Ranking

204 / 385

Overall Ranking

384 / 4281

Industry

Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Collplant Biotechnologies Ltd Highlights

StrengthsRisks

CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Growing

The company is in a growing phase, with the latest annual income totaling USD 2.37M.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 2.37M.

Overvalued

The company’s latest PE is -0.29, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 1.89M shares, decreasing 10.36% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 21.95K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.53.

Analyst Rating

Based on 0 analysts

Current Rating

11.000

Target Price

+3425.64%

Upside Space

Collplant Biotechnologies Ltd News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 0 analysts

Current Rating

11.000

Target Price

+3425.64%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

496

Total

Median

Average

Company name

Ratings

Analysts

Collplant Biotechnologies Ltd

CLGN

Beigene Ltd

ONC

argenx SE

ARGX

IQVIA Holdings Inc

IQV

Ionis Pharmaceuticals Inc

IONS

Insmed Inc

INSM

...

Indicators

Indicators

Sell(3)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.008

Sell

RSI(14)

32.337

Neutral

STOCH(KDJ)(9,3,3)

16.606

Sell

ATR(14)

0.036

High Vlolatility

CCI(14)

-221.925

Oversold

Williams %R

96.951

Oversold

TRIX(12,20)

-0.620

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.306

Sell

MA10

0.311

Sell

MA20

0.337

Sell

MA50

0.357

Sell

MA100

0.412

Sell

MA200

1.014

Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Collplant Biotechnologies Ltd Info

Ticker SymbolCLGN

CompanyCollplant Biotechnologies Ltd

CEORotem (Eran)

Websitehttps://www.collplant.com

Shareholders

Shareholders

Proportion

Sagy (Ami)

11.36%

Loewenbaum (George Walter II)

8.71%

St. Denis J. Villere & Company, LLC

4.21%

Pinnacle Associates Ltd.

3.82%

Loewenbaum (Lilian Shaw)

2.82%

Other

69.08%

Popular Instruments

FAQs

What is the current price of Collplant Biotechnologies Ltd (CLGN)?



The current price of Collplant Biotechnologies Ltd (CLGN) is 0.30.

What is the symbol of Collplant Biotechnologies Ltd?



The ticker symbol of Collplant Biotechnologies Ltd is CLGN.

What is the 52-week high of Collplant Biotechnologies Ltd?



The 52-week high of Collplant Biotechnologies Ltd is 4.98.

What is the 52-week low of Collplant Biotechnologies Ltd?



The 52-week low of Collplant Biotechnologies Ltd is 0.49.

What is the market capitalization of Collplant Biotechnologies Ltd?



The market capitalization of Collplant Biotechnologies Ltd is 3.82M.

What is the Earnings Per Share (EPS TTM) of Collplant Biotechnologies Ltd (CLGN)?



The Earnings Per Share (EPS TTM) of Collplant Biotechnologies Ltd (CLGN) is -0.94.